|
|
           
|
|
|
|
|
|
|
|
 
|
|
Rv2043c More about Rv2043c on TBDB.org More about Rv2043c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv2043c: Codons 40 to 44: 4 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Hou L Epi Infect 2000 | TAC/CAC | 121 | 41 | Tyr/His | 1996-1998 | China | PCR-SSCP | Whole gene | ZHRE | 600 | Proportion method, BACTEC 460 | 35/65 | 1/0 | - | - |
| Hirano K TLD 1997 | TAC/TAA | 123 | 41 | Tyr/STOP | 1997 | Thailand | Sequencing | Whole gene | ZHRSE | >800 | Middlebrook 7H11 agar w/ pH of 6.0 | 33/168 | 1/0 | - | - |
| Sreevatsan S AAC 1997 | TAC/TAG | 123 | 41 | Tyr/STOP | 1996 | Diverse geographical locations | Sequencing | Whole gene | Z | - | BACTEC 460 | 67/118 | 1/0 | - |  |
| Hirano K TLD 1997 | CAC/CCC | 128 | 43 | His/Pro | 1997 | Thailand | Sequencing | Whole gene | ZHR | >800 | Proportion method | 33/168 | 1/0 | - | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |